BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 17509356)

  • 21. Association detection between genetic variants in the microRNA binding sites of toll-like receptors signaling pathway genes and bladder cancer susceptibility.
    Cheng S; Liu J; Zhang Y; Lin Y; Liu Q; Li H; Huang J; Zhang P
    Int J Clin Exp Pathol; 2014; 7(11):8118-26. PubMed ID: 25550860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toll-like receptors in urothelial cells--targets for cancer immunotherapy.
    LaRue H; Ayari C; Bergeron A; Fradet Y
    Nat Rev Urol; 2013 Sep; 10(9):537-45. PubMed ID: 23979666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toll-like receptor 7 agonist therapy with imidazoquinoline enhances cancer cell death and increases lymphocytic infiltration and proinflammatory cytokine production in established tumors of a renal cell carcinoma mouse model.
    Kauffman EC; Liu H; Schwartz MJ; Scherr DS
    J Oncol; 2012; 2012():103298. PubMed ID: 22481916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravesical Toll-like receptor 7 agonist R-837: optimization of its formulation in an orthotopic mouse model of bladder cancer.
    Hayashi T; Crain B; Corr M; Chan M; Cottam HB; Maj R; Barberis A; Leoni L; Carson DA
    Int J Urol; 2010 May; 17(5):483-90. PubMed ID: 20337728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasmacytoid dendritic cell-derived type I interferon is crucial for the adjuvant activity of Toll-like receptor 7 agonists.
    Rajagopal D; Paturel C; Morel Y; Uematsu S; Akira S; Diebold SS
    Blood; 2010 Mar; 115(10):1949-57. PubMed ID: 20065291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishment of orthotopic mouse superficial bladder tumor model for studies on intravesical treatments.
    Horiguchi Y; Kikuchi E; Ozu C; Nishiyama T; Oyama M; Horinaga M; Yoshioka K; Tachibana M
    Hum Cell; 2008 Aug; 21(3):57-63. PubMed ID: 18667021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The antitumoral mode of action of imiquimod and other imidazoquinolines.
    Schön M; Schön MP
    Curr Med Chem; 2007; 14(6):681-7. PubMed ID: 17346155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumour growth inhibition by an imidazoquinoline is associated with c-Myc down-regulation in urothelial cell carcinoma.
    Liu H; Schwartz MJ; Hwang DH; Scherr DS
    BJU Int; 2008 Apr; 101(7):894-901. PubMed ID: 18241249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor effects of an imidazoquinoline in renal cell carcinoma.
    Schwartz MJ; Liu H; Hwang DH; Kawamoto H; Scherr DS
    Urology; 2009 May; 73(5):1156-62. PubMed ID: 19118885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacille Calmette-Guerin can induce cellular apoptosis of urothelial cancer directly through toll-like receptor 7 activation.
    Yu DS; Wu CL; Ping SY; Keng C; Shen KH
    Kaohsiung J Med Sci; 2015 Aug; 31(8):391-7. PubMed ID: 26228277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MB49 murine urothelial carcinoma: molecular and phenotypic comparison to human cell lines as a model of the direct tumor response to bacillus Calmette-Guerin.
    Chen F; Zhang G; Cao Y; Hessner MJ; See WA
    J Urol; 2009 Dec; 182(6):2932-7. PubMed ID: 19853870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A molecular complex of bovine milk protein and oleic acid selectively kills cancer cells in vitro and inhibits tumour growth in an orthotopic rat bladder tumour model.
    Xiao Z; Mak A; Koch K; Moore RB
    BJU Int; 2013 Jul; 112(2):E201-10. PubMed ID: 23356235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor effects of imidazoquinolines in urothelial cell carcinoma of the bladder.
    Smith EB; Schwartz M; Kawamoto H; You X; Hwang D; Liu H; Scherr DS
    J Urol; 2007 Jun; 177(6):2347-51. PubMed ID: 17509356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The imidazoquinolines and their place in the therapy of cutaneous disease.
    Smith KJ; Hamza S; Skelton H
    Expert Opin Pharmacother; 2003 Jul; 4(7):1105-19. PubMed ID: 12831337
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.